Navigation Links
The Chris Elliott Fund Commends New Bill to Improve Access to Oral Chemotherapy Drugs
Date:5/13/2013

Seattle, WA (PRWEB) May 13, 2013

The Chris Elliott Fund commends the work of Congressman Brian Higgins, NY-26 , for introducing the Cancer Drug Coverage Parity Act which would require health insurance companies to equally cover and reimburse intravenous/injectable and orally administered anti-cancer medication. “Doctors, not insurance companies, should decide the best course of treatment for cancer patients. This legislation will better enable patients access to the best available treatments that will extend and improve their quality of life” said Higgins in a press release on the introduction of the act on May 2nd 2013.

Many brain tumor patients face mounting costs throughout treatment, one of which can be oral chemo therapy treatment. “There are so many great treatments out there and unfortunately too often brain cancer patients are left with the question of who is going to pay for it” says Dellann Elliott Mydland, Chris Elliott Fund Founder & President, “it is unfortunate to see individuals and families bankrupted by cancer care and treatment, and this Act aims to change that.” The Chris Elliott Fund supports this bill and offers that it is a great bridge between science and healthcare, finding affordable solutions for the care people need. It is part of CEF's mission to provide immediate equal access to advance treatment, in hopes to end brain cancer. Financial concerns are a specific focus of The Chris Elliott Fund, earlier this year the organization hosted a 2-part webinar in their Brains Matter Webinar Series on “A Brain Tumor Patient’s Guide to Insurance & Financial Resources”. For updates on webinars and educational information, or to follow news on this Act email the Chris Elliott Fund at WeCare(at)EndBrainCancer(dot)com.

About the Chris Elliott Fund:
The Chris Elliott Fund (CEF) is a patient advocacy organization and national 501(c)(3) non-profit with corporate offices in Seattle, Washington, with goals to end brain cancer through education, advocacy, awareness and support. Established in 2002, CEF has grown to provide support nationally for brain cancer and brain tumor patients seeking guidance, advice, and assistance to demystify finding the absolute best course of treatment for their brain cancer or brain tumor. The organization and its advocates, on average, serve 500-800 patients and caregivers per month, free of charge. If we can help, please contact us at WeCare(at)EndBrainCancer(dot)com.

Read the full story at http://www.prweb.com/releases/ChrisElliottFundSupports/CancerCoverageParityAct/prweb10707754.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Christopher Oliver Agency Creates Advanced Tracking System for Controversial Law of Attraction Weight Loss Book
2. The Chris Elliott Fund to Honor the Late Kathi Goertzen, Longtime Western Washington News Anchor, with Inspiration Award at May 16th Brains Matter Auction and Luncheon
3. Turmeric Products Are Not All Alike, Christian Wilde's Newly Released, Enhanced Turmeric+ Formula (with 7 Additional Synergizing Ingredients) Is a Totally Unique.
4. Christian Alcohol Rehab Announced by Recovery Associates
5. Actors, Models and Talent for Christ Announces New Audition Sites for Up and Coming Talent of All Ages
6. Actors, Models and Talent for Christ Grad Julian Silva Cast in Les Miserables US and Canada Tour 2013 performing in New York April 30-May 5
7. Actors, Models and Talent for Christ (AMTC) Prepares for Auditions in Dallas on Monday, May 6th
8. Nashville Awaits Talent Auditions This Friday, April 26th Hosted by Actors, Models and Talent for Christ
9. Actors, Models & Talent for Christ Graduate, Taylor Beckham, Is Stolen by Team Blake And Stays in The Voice Competition
10. Actors, Models & Talent for Christ Graduate, Charles Michael Davis in Grey’s Anatomy and Big Screen Movie Another Stateside
11. Actors, Models and Talent for Christ (AMTC) Prepares for Atlanta Auditions on Monday, April 29th
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... May 26, 2016 , ... Catalent ... for drugs, biologics, consumer health and global clinical supply services, today announced two ... support the company’s continued investment and strategic growth plans in the Asia Pacific ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... supply chain solutions, today announced the organization has earned its ISO 13485 certification, ... and is compliant with all rules and policies associated with ISO quality standard ...
(Date:5/26/2016)... New York, NY (PRWEB) , ... May 26, ... ... cell researcher, founder of Mehling Orthopedics and chief medical officer of Blue Horizon ... Musculoskeletal Disease and Regeneration. The conference was held during May 5-6, 2016 in ...
(Date:5/26/2016)... , ... May 26, 2016 , ... ... to oncology professionals, has added National Cancer Institute-designated University of Virginia (UVA) ... In this new partnership, OncLive’s editorial and marketing teams will publicize and promote ...
(Date:5/26/2016)... ... May 26, 2016 , ... Metcalf & ... over 20 years of experience in leading technology and human resources operations for ... university teaching, Morrow-Fox will be featured on Metcalf’s VoiceAmerica radio show , ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... 25,2016 FDA 510(k) clearance ... platform for urological and surgical applications ... of Cellvizio®, the multidisciplinary confocal laser endomicroscopy (CLE) ... the US with the 12 th 510(k) ... (FDA). This new FDA clearance covers Confocal Miniprobes ...
(Date:5/25/2016)... , May 25, 2016  According to Kalorama ... $381 billion in 2015.  Though these are challenging ... of opportunity for success for companies that remain ... search of new growth prospects medical device companies ... research and development (R&D) than do companies in ...
(Date:5/25/2016)... MedDay, a biotechnology company focused on the treatment ... "High doses of biotin in progressive multiple sclerosis: extension phase ... Ayman Tourbah , Principal Investigator of the Phase 3 ... Neurology (EAN) in Copenhagen, Denmark . The ... on Sunday, 29 May 2016 from 14:45 to 16:15 CEST ...
Breaking Medicine Technology: